Evidence map›Paper›PMID 22949783›Full record

ArticleTexas Heart Institute journal2012

Hyperinsulinemia euglycemia therapy for calcium channel blocker overdose: a case report.

Anushree Agarwal, Siegfried W Yu, Abdul Rehman, Joseph Q Henkle

Open access · greenAbstract readCase Reports
In one paragraph

Article in Texas Heart Institute journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Treatment for calcium channel blocker poisoning: a systematic review.Clinical toxicology (Philadelphia, Pa.) · 2014
    Pooled it
  2. Article
  3. Article
  4. Management of Calcium Channel Blocker Toxicity in the Pediatric Patient.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Anushree AgarwalDepartment of Internal Medicine, Southern Illinois University School of Medicine, Springfield, Illinois 62702, USA. anudr28@gmail.com
Siegfried W Yu
Abdul Rehman
Joseph Q Henkle
Southern Illinois University School of Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the case of a patient with calcium channel blocker toxicity who was treated successfully with hyperinsulinemia euglycemia therapy, without prior use of vasopressors. The patient was a 60-year-old man with schizoaffective disorder who presented with severe hemodynamic compromise after an intentional overdose of 5,400 mg of extended-release diltiazem. He had been admitted to the hospital twice before for attempted suicide with diltiazem and nifedipine, respectively. During the previous admissions, conventional treatments were used, and complications included hemodynamic compromise, ischemic bowel requiring ileostomy, and a prolonged hospital stay. During the current admission, the patient's clinical condition failed to improve after treatment with charcoal, fluid resuscitation, calcium, and glucagon. Eight hours after admission, hyperinsulinemia euglycemia therapy was initiated; 3 hours later, the patient's hemodynamic status showed sustained improvement. His bradycardia and hypotension resolved without cardiac pacing or vasopressors. Hyperinsulinemia euglycemia therapy is a potentially life-saving treatment for calcium channel blocker toxicity. We suggest that such therapy should be considered early, in conjunction with conventional therapy, for the treatment of calcium channel blocker overdose in patients not responding to initial treatment.

Indexed as

Glucose Clamp TechniqueHyperinsulinismBlood PressureBradycardiaCalcium Channel BlockersCardiovascular DiseasesDiltiazemHeart RateHumansHypoglycemic AgentsHypotensionInfusions, IntravenousInsulinMaleMiddle AgedPoisoningCalcium Channel BlockersDiltiazemHypoglycemic AgentsInsulinCalcium channel blockersdiltiazemhyperinsulinemia euglycemia therapyinsulin/therapeutic use

Identifiers

PMID22949783
PMCPMC3423274
OpenAlexW80336950

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.